OUR team
We are a group of antidisciplinary scientists and builders working at the intersection of engineering and biology.
.jpg){kind=avatar}
.jpg)
Abdul Mohammed
Associate Director - Genomic Applications
.jpg){kind=avatar}
.jpg)
Alex Gushulak
Mechanical Engineer
.jpg){kind=avatar}
.jpg)
Alexandra Franklin
Senior Operations Associate
Alice Wong
Genomics Sequencing Technician
.jpg){kind=avatar}
.jpg)
Allyson Miller
Senior Operations Associate
.jpg){kind=avatar}
.jpg)
Ben Fargiano
Mechanical Engineer
.jpg){kind=avatar}
.jpg)
Cédric Viry
Senior Materials/R&D Engineer
.jpg){kind=avatar}
.jpg)
Daniel Giguere
Scientist - Genomic Applications
Febriana Pangestu
Associate Scientist
.jpg){kind=avatar}
.jpg)
Gabriella Davis
Research Associate
.jpg){kind=avatar}
.jpg)
Jaiden Cruger
Systems Integration Engineer
.jpg){kind=avatar}
.jpg)
James Ferguson
Principal Software Engineer
.jpg){kind=avatar}
.jpg)
Keith Farnsworth
Chief Commercial Officer
.jpg){kind=avatar}
.jpg)
Liam Masters
Software Engineer
.jpg){kind=avatar}
.jpg)
Nic Bryant
Staff Product Manager
.jpg){kind=avatar}
.jpg)
Nicole Arruda
Scientist - Genomics Applications
.jpg){kind=avatar}
.jpg)
Pierre Sphabmixay
Senior R&D Engineer
.jpg){kind=avatar}
.jpg)
Rithika Raj Kumar Pradeep
Research Associate
Saikumar Karyala
Senior Scientist - Genomic Applications
.jpg){kind=avatar}
.jpg)
Udayan Umapathi
CEO and Head of Product
Board of directors
We are proud to have the support of industry CEOs who have built large, successful companies providing us strategic advice.
Natan Linder
CEO
Tulip Interfaces
David Singer
Director
Managing Partner, Maverick Ventures
Maxim Lobovsky
CEO
Formlabs
Udayan Umapathi
CEO and Head of Product
Volta Labs
INDIVIDUAL INVESTORS AND ADVISORS
Standing on the shoulders of industry giants.
John Stuelpnagel
Co-founder & Board Member
Illumina, 10X Genomics & Others
Paul McEwan
Co- founder & Board Member
Kapa Biosystems & Others
Preston Estep
Director
Harvard Personal Genome Project
Maryke Appel
Technical Director (former)
Kapa Biosystems & Roche
George Church
Professor
Harvard Medical School
Investors
Backed by investors with long term perspective in genomics
